SIMPONI ARIA (also known as Golimumab)
Mechanism:
Simponi aria is an antibody that block tumor necrosis factor alpha (TNFα) which is a core inflammatory modulator.
Indications:
Contraindications:
Patients with active infection should not be started on Simponi aria. Patients with Hepatitis B and congestive heart failure should consult with their physicians prior to starting on Simponi Aria.
Administration:
Simponi is typically administered as an infusion over thirty minutes at weeks 0, 4, and then every 8 weeks thereafter.